Why pay $50 billion for the headache known as Tylenol?

episode

Marketplace All-in-One not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Marketplace All-in-One

"Marketplace" Live 1h 12m · 11 Apr 2026

Navigating long-term unemployment 25 min · 10 Apr 2026

Rejecting climate doomerism with solarpunk 13 min · 10 Apr 2026

David Brancaccio reflects on thousands of conversations 7 min · 10 Apr 2026

"Nobody can time the market" 7 min · 10 Apr 2026

Bytes: Week in Review — Anthropic's new AI model, a referendum on data centers, and NASA livestreams journey to space 11 min · 10 Apr 2026

All episodes from Marketplace All-in-One →

Report any issue

Source

Recorded04 Nov 2025

Publisherfeeds.publicradio.org ↗

Handlerec:2891943

Show notes

Kimberly-Clark’s stock closed down 14% yesterday after it gambled nearly $50 billion on a company called Kenvue, maker of Listerine, Band-Aids, and Tylenol — the painkiller HHS Secretary Robert F. Kennedy wants to link to autism, despite a lack of scientific evidence. People are now suing Kenvue, a potential liability that will become Kimberly-Clark's problem. We unpack. Also: potential changes to public service loan forgiveness and a speech by Federal Reserve Governor Lisa Cook.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in